当前位置: 首页 > 期刊 > 《临床心身疾病杂志》 > 2006年第4期
编号:11155808
舍曲林联合心理治疗抑郁和焦虑障碍共病临床研究
http://www.100md.com 《临床心身疾病杂志》 2006年第4期
抑郁焦虑障碍;共病;舍曲林;心理治疗,,抑郁焦虑障碍;共病;舍曲林;心理治疗,【摘要】,【关键词】,1对象与方法,2结果,3讨论,参考文献
     【摘要】 目的 研究舍曲林联合心理治疗治疗抑郁、焦虑障碍共病的疗效及安全性。 方法 将58例抑郁、焦虑障碍共病患者随机分为舍曲林联合心理治疗组和单用舍曲林治疗组各29例进行对照研究,疗程8w,采用汉密顿焦虑量表、汉密顿抑郁量表及药物副作用量表评定临床疗效和不良反应。 结果 研究组抗焦虑、抗抑郁起效均较对照组快(P<0.05或0.01),抗焦虑疗效优于对照组(P<0.05),治疗8w末两组抗抑郁疗效相当。结论 舍曲林联合心理治疗治疗抑郁、焦虑障碍共病起效快,疗效显著,安全性高,依从性好。

    【关键词】 抑郁焦虑障碍;共病;舍曲林;心理治疗

    Sertraline plus psychotherapy in the treatment of comorbid depression and anxiety

    Niu Huiming, Xie Yufeng,Pei Genxiang

    (Tianshui Mental Hospital ,741000,Gansu,China)

    【Abstract】 Objective To study efficacy and safety sertraline plus psychotherapy in the treatment of comorbid depression and anxiety. Methods 58 patients were randomly assigned into the sertraline plus psychotherapy group(n=29) and single sertraline group(n=29) for 8 weeks. Efficacies were assessed with the Hamilton Anxiety Scale(HAMA ) and the Hamilton Depression Scale(HAMD) and side effects with the Treatment Emergent Symptom Scale(TESS). Results Compared with control group, research group took antianxiety and depression effects quicker(P<0.05 or 0.01) and antianxious efficacy was better(P<0.05), and antidepressive efficacy of the 2 groups was equivalent. Conclusion Sertraline plus psychotherapy takes effect quicker and has significant efficacy, higher safety and well compliance in the treatment of comorbid depression and anxiety. ......

您现在查看是摘要页,全文长 7033 字符